ATE475640T1 - Antagonisten des opioidrezeptors - Google Patents

Antagonisten des opioidrezeptors

Info

Publication number
ATE475640T1
ATE475640T1 AT05724567T AT05724567T ATE475640T1 AT E475640 T1 ATE475640 T1 AT E475640T1 AT 05724567 T AT05724567 T AT 05724567T AT 05724567 T AT05724567 T AT 05724567T AT E475640 T1 ATE475640 T1 AT E475640T1
Authority
AT
Austria
Prior art keywords
sup
antagonists
opioid receptor
racemate
diastereomer
Prior art date
Application number
AT05724567T
Other languages
English (en)
Inventor
La Torre Marta Garcia De
Charles Mitch
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE475640T1 publication Critical patent/ATE475640T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/46Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05724567T 2004-03-12 2005-03-08 Antagonisten des opioidrezeptors ATE475640T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04380058 2004-03-12
US55318404P 2004-03-15 2004-03-15
PCT/US2005/007051 WO2005090286A1 (en) 2004-03-12 2005-03-08 Opioid receptor antagonists

Publications (1)

Publication Number Publication Date
ATE475640T1 true ATE475640T1 (de) 2010-08-15

Family

ID=34961741

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05724567T ATE475640T1 (de) 2004-03-12 2005-03-08 Antagonisten des opioidrezeptors

Country Status (7)

Country Link
US (1) US7381750B2 (de)
EP (1) EP1727788B1 (de)
AT (1) ATE475640T1 (de)
CA (1) CA2558568A1 (de)
DE (1) DE602005022572D1 (de)
ES (1) ES2347577T3 (de)
WO (1) WO2005090286A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140236A (en) * 2002-09-19 2009-12-31 Lilly Co Eli Diarylether compounds useful as opioid receptor antagonists
DE602005012380D1 (de) 2004-03-15 2009-03-05 Lilly Co Eli 4-(5-(aminomethyl)-indol-1-ylmethyl)benzamidderivate und verwandte verbindungen als opioidrezeptorantagonisten zur behandlung von fettleibigkeit
CA2662766C (en) 2006-09-08 2011-08-09 Pfizer Products Inc. Diaryl ether derivatives and uses thereof
JP2010527980A (ja) 2007-05-22 2010-08-19 プロシディオン・リミテッド 代謝障害を治療するための二環状アリールおよびヘテロアリール化合物
JP2010538055A (ja) 2007-09-07 2010-12-09 プロシディオン・リミテッド 二環式アリールおよびヘテロアリール受容体モジュレーター
EA017484B1 (ru) * 2008-01-22 2012-12-28 Эли Лилли Энд Компани Селективный антагонист опиоидных рецепторов каппа
JP5797655B2 (ja) * 2009-09-18 2015-10-21 アドラー・コーポレーション 消化管障害のためのオピオイド受容体アンタゴニストの使用
US8425885B2 (en) * 2009-11-09 2013-04-23 Conopco, Inc. Substituted 3-(phenoxymethyl) benzyl amines and personal care compositions
US8309064B2 (en) 2009-11-09 2012-11-13 Conopco, Inc. Skin care compositions comprising phenoxyalkyl amines
US10299475B2 (en) 2013-08-23 2019-05-28 Ishihara Sangyo Kaisha, Ltd. Pesticide
WO2016144702A1 (en) 2015-03-06 2016-09-15 Pharmakea, Inc. Lysyl oxidase-like 2 inhibitors and uses thereof
WO2016144703A1 (en) 2015-03-06 2016-09-15 Pharmakea, Inc. Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
MX2019002612A (es) 2016-09-07 2019-08-21 Pharmakea Inc Usos de un inhibidor de lisil-oxidasa tipo 2.
MX390964B (es) 2016-09-07 2025-03-21 Pharmakea Inc Formas cristalinas de un inhibidor tipo lisil oxidasa 2 y metodos de realizacion.
US12161622B2 (en) 2021-05-04 2024-12-10 Janssen Pharmaceuticals, Inc. Compositions and methods for the treatment of depression
TW202400135A (zh) 2022-03-07 2024-01-01 美商健生醫藥公司 包含阿替卡普蘭之組成物
WO2023170550A1 (en) 2022-03-07 2023-09-14 Janssen Pharmaceuticals, Inc. Polymorph forms of aticaprant for use in treating major depressive disorder

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA754192B (en) 1974-08-05 1976-06-30 Ciba Geigy Ag 2-(aralkoxyphenyl)-1-(bis-arylalkylamino)-alkanes
GB9104656D0 (en) 1991-03-05 1991-04-17 Zambeletti Spa L Pharmaceuticals
GB9417532D0 (en) * 1994-08-31 1994-10-19 Zeneca Ltd Aromatic compounds
HUP0101275A3 (en) * 1998-03-26 2002-12-28 Japan Tobacco Inc Amide derivatives and pharmaceutical compositions containing them as nociceptin antagonists
SI1859798T1 (sl) 2001-03-29 2016-07-29 Eli Lilly And Company N-(2-ariletil) benzil amini kot antagonisti 5-ht6 receptorja
MY140236A (en) 2002-09-19 2009-12-31 Lilly Co Eli Diarylether compounds useful as opioid receptor antagonists
ATE406360T1 (de) 2003-03-07 2008-09-15 Lilly Co Eli Antagonisten der opioidrezeptoren
DE10317098A1 (de) 2003-04-14 2004-07-22 Infineon Technologies Ag Verfahren zur Herstellung eines Bipolartransistors
US7196100B2 (en) 2003-12-12 2007-03-27 Eli Lilly And Company Opioid receptor antagonists
AU2004312312A1 (en) 2003-12-22 2005-07-21 Eli Lilly And Company Opioid receptor antagonists

Also Published As

Publication number Publication date
ES2347577T3 (es) 2010-11-02
US7381750B2 (en) 2008-06-03
DE602005022572D1 (de) 2010-09-09
EP1727788A1 (de) 2006-12-06
WO2005090286B1 (en) 2005-12-22
CA2558568A1 (en) 2005-09-29
US20070287751A1 (en) 2007-12-13
WO2005090286A1 (en) 2005-09-29
EP1727788B1 (de) 2010-07-28

Similar Documents

Publication Publication Date Title
ATE545413T1 (de) Antagonisten des opioidrezeptors
MY140236A (en) Diarylether compounds useful as opioid receptor antagonists
DE602005022572D1 (de) Antagonisten des opioidrezeptors
MXPA05009367A (es) Antagonistas del receptor opioide.
TW200716520A (en) 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
MX2009004900A (es) Arilamidas sustituidas por tiazol u oxazol.
EA200801998A1 (ru) ПИРИДИН[3,4-b]ПИРАЗИНОНЫ
WO2002074758A3 (en) Novel amines as histamine-3 receptor ligands and their therapeutic applications
TW200728307A (en) Novel spirochromanone derivatives
TNSN07349A1 (fr) Derives de n-(n-sulfonylaminomethyl) cyclopropanecarboxamide utiles pour le traitement de la douleur
TW200716574A (en) The preparation and use of compounds as aspartyl protease inhibitors
WO2006098918A3 (en) Substituted gamma lactams as therapeutic agents
WO2004000808A3 (en) N-substituted piperidine derivatives as serotonin receptor agents
MXPA05011411A (es) 1,4-diazepinas sustituidas y usos de las mismas.
ATE446962T1 (de) Thiazolopyridinon-derivate als mch- rezeptorantagonisten
BG108650A (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
MXPA05013474A (es) Derivados de quinolilamida como antagonistas de ccr-5.
ATE512961T1 (de) Amorphes nebivolol hydrochlorid und seine herstellung
ATE308522T1 (de) Opioidrezeptorantagonisten
WO2007088276A3 (fr) Derives de sulfonamides, leur preparation et leur application en therapeutique
SI1828177T1 (sl) Novi antagonisti mch receptorja
WO2006113552A3 (en) Cyanoarylamines
MX2008001606A (es) Piperazinas substituidas como antagonistas de receptor de glutamato metabotropico.
ATE399164T1 (de) Antagonisten des opioidrezeptors
WO2004080411A3 (en) Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties